2. Academic Validation
  3. PI3Kδ inhibition reduces TNF secretion and neuroinflammation in a mouse cerebral stroke model

PI3Kδ inhibition reduces TNF secretion and neuroinflammation in a mouse cerebral stroke model

  • Nat Commun. 2014 Mar 14;5:3450. doi: 10.1038/ncomms4450.
Pei Ching Low 1,  Silvia Manzanero 2,  Nika Mohannak 3,  Vinod K Narayana 3,  Tam H Nguyen 3,  David Kvaskoff 3,  Faith H Brennan 4,  Marc J Ruitenberg 5,  Mathias Gelderblom 6,  Tim Magnus 6,  Hyun Ah Kim 7,  Brad R S Broughton 7,  Christopher G Sobey 7,  Bart Vanhaesebroeck 8,  Jennifer L Stow 9,  Thiruma V Arumugam 2,  Frédéric A Meunier 3
Affiliations

Affiliations

  • 1 1] Queensland Brain Institute, The University of Queensland, Brisbane, Queensland 4072, Australia [2].
  • 2 1] School of Biomedical Sciences, The University of Queensland, Brisbane, Queensland 4072, Australia [2].
  • 3 Queensland Brain Institute, The University of Queensland, Brisbane, Queensland 4072, Australia.
  • 4 School of Biomedical Sciences, The University of Queensland, Brisbane, Queensland 4072, Australia.
  • 5 1] Queensland Brain Institute, The University of Queensland, Brisbane, Queensland 4072, Australia [2] School of Biomedical Sciences, The University of Queensland, Brisbane, Queensland 4072, Australia.
  • 6 Department of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • 7 Vascular Biology and Immunopharmacology Group, Department of Pharmacology, Monash University, Clayton, Victoria 3800, Australia.
  • 8 UCL Cancer Institute, Paul O'Gorman Building, University College London, 72 Huntley Street London WC1E 6DD, UK.
  • 9 Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland 4072, Australia.
PMID: 24625684 DOI: 10.1038/ncomms4450
Abstract

Stroke is a major cause of death worldwide and the leading cause of permanent disability. Although reperfusion is currently used as treatment, the restoration of blood flow following ischaemia elicits a profound inflammatory response mediated by proinflammatory cytokines such as tumour necrosis factor (TNF), exacerbating tissue damage and worsening the outcomes for stroke patients. Phosphoinositide 3-kinase delta (PI3Kδ) controls intracellular TNF trafficking in macrophages and therefore represents a prospective target to limit neuroinflammation. Here we show that PI3Kδ inhibition confers protection in ischaemia/reperfusion models of stroke. In vitro, restoration of glucose supply following an episode of glucose deprivation potentiates TNF secretion from primary microglia-an effect that is sensitive to PI3Kδ inhibition. In vivo, transient middle cerebral artery occlusion and reperfusion in kinase-dead PI3Kδ (p110δ(D910A/D910A)) or wild-type mice pre- or post-treated with the PI3Kδ Inhibitor CAL-101, leads to reduced TNF levels, decreased leukocyte infiltration, reduced infarct size and improved functional outcome. These data identify PI3Kδ as a potential therapeutic target in ischaemic stroke.

Figures
Products